Emery S - Search Results

1

Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial.

Carey D, Wand H, Martin A, Rothwell S, Emery S, Cooper DA, Carr A; Rosey Investigators. Carey D, et al. Among authors: emery s. AIDS. 2005 Aug 12;19(12):1325-7. doi: 10.1097/01.aids.0000180106.11383.cc. AIDS. 2005. PMID: 16052090 Clinical Trial.

2

The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD; ESPRIT Study Group. Emery S, et al. Control Clin Trials. 2002 Apr;23(2):198-220. doi: 10.1016/s0197-2456(01)00179-9. Control Clin Trials. 2002. PMID: 11943448 Clinical Trial.

3

Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.

French M, Amin J, Roth N, Carr A, Law M, Emery S, Drummond F, Cooper D; OzCombo 2 investigators. French M, et al. Among authors: emery s. HIV Clin Trials. 2002 May-Jun;3(3):177-85. doi: 10.1310/9n21-1hg1-7n1q-jkw1. HIV Clin Trials. 2002. PMID: 12032876 Clinical Trial.

4

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing.

Birch C, Middleton T, Hales G, Cooper D, Law M, Crowe S, Hoy J, Emery S. Birch C, et al. Among authors: emery s. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):57-61. doi: 10.1097/00126334-200301010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 12514414

5

Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals.

Clegg A, Williamson P, Biti R, Cooper D, Emery S, Carr A, Stewart G. Clegg A, et al. Among authors: emery s. Clin Immunol. 2003 Jan;106(1):36-40. doi: 10.1016/s1521-6616(02)00020-7. Clin Immunol. 2003. PMID: 12584049 Clinical Trial.

6

Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.

Sirivichayakul S, Ruxrungtham K, Ungsedhapand C, Techasathit W, Ubolyam S, Chuenyam T, Emery S, Cooper D, Lange J, Phanuphak P. Sirivichayakul S, et al. Among authors: emery s. AIDS. 2003 Sep 5;17(13):1889-96. doi: 10.1097/00002030-200309050-00007. AIDS. 2003. PMID: 12960821 Clinical Trial.

7

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA; Rosey investigators. Carr A, et al. Among authors: emery s. Lancet. 2004 Feb 7;363(9407):429-38. doi: 10.1016/S0140-6736(04)15489-5. Lancet. 2004. PMID: 14962523 Clinical Trial.

8

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA; Mitochondrial Toxicity Study Group. Martin A, et al. Among authors: emery s. AIDS. 2004 Apr 30;18(7):1029-36. doi: 10.1097/00002030-200404300-00011. AIDS. 2004. PMID: 15096806 Clinical Trial.

9

A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals.

Pett SL, Williams LA, Day RO, Lloyd AR, Carr AD, Clezy KR, Emery S, Kaplan E, McPhee DA, McLachlan AJ, Gelder FB, Lewin SR, Liauw W, Williams KM. Pett SL, et al. Among authors: emery s. HIV Clin Trials. 2004 Mar-Apr;5(2):91-8. doi: 10.1310/1FLN-8KFC-5HEQ-K19J. HIV Clin Trials. 2004. PMID: 15116285 Clinical Trial.

10

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.

Ungsedhapand C, Srasuebkul P, Cardiello P, Ruxrungtham K, Ratanasuwan W, Kroon ED, Tongtalung M, Juengprasert N, Ubolyam S, Siangphoe U, Emery S, Lange JM, Cooper DA, Phanuphak P; HIV-NAT 002 and HIV-NAT 003 Study Team. Ungsedhapand C, et al. Among authors: emery s. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):693-701. doi: 10.1097/00126334-200406010-00006. J Acquir Immune Defic Syndr. 2004. PMID: 15167288 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,016 results

Search Page